Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 18/20 | 0.59 |
| ▸ | FNTB | P49356 | 18/20 | 0.59 |
| ▸ | PGGT1B | P53609 | 13/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2352908 | 0.74 | FNTA (1.00) | FNTAFNTBPGGT1BKCNH2CYP3A4 | |
| SCHEMBL7937545 | 0.74 | FNTA (1.00) | FNTAFNTBPGGT1BKCNH2CYP3A4 | |
| SCHEMBL2352916 | 0.74 | FNTA (1.00) | FNTAFNTBPGGT1BKCNH2CYP3A4 | |
| Hydrochloric Acid SCHEMBL7939170 | 0.74 | FNTA (0.98) | FNTAFNTBPGGT1BKCNH2CYP3A4 | |
| Hydrochloric Acid SCHEMBL7939168 | 0.74 | FNTA (0.98) | FNTAFNTBPGGT1BKCNH2CYP3A4 | |
| SCHEMBL7936033 | 0.73 | KCNH2 (0.48) | FNTAFNTBPGGT1BKCNH2CYP3A4 | |
| SCHEMBL7927442 | 0.72 | FNTA (0.46) | FNTAFNTBPGGT1BKCNH2CYP3A4 | |
| SCHEMBL12932153 | 0.72 | FNTA (0.83) | FNTAFNTBPGGT1BKCNH2CYP3A4 | |
| SCHEMBL7699025 | 0.71 | FNTA (1.00) | FNTAFNTBPGGT1BKCNH2CYP3A4 | |
| SCHEMBL7699026 | 0.71 | FNTA (1.00) | FNTAFNTBPGGT1BKCNH2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002057223-A2 | COMPOUNDS AZEPANE, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS | LES LABORATOIRES SERVIER (FR) | 2002-07-25 | — | — | WO | claimed |